Comprehensive Classification System for Extracellular Vesicle Biomarkers Across Physiology, Disease, Therapeutics, and Regenerative Medicine
Program Code: HEMOREGEN-DX-001
Division: HEMOREGEN-DX
Parent Program: HEMOREGEN-721
Classification: Diagnostic and Biomarker Intelligence Platform
Status: Master Reference Atlas v1.0
EXECUTIVE SUMMARY
The EV Biomarker Reference Atlas establishes the master classification system for extracellular vesicle biomarkers across all physiological and pathological states.
Within PROJECT HEMOREGEN-721, EV biomarkers are viewed as dynamic biological intelligence signals capable of reporting:
- Organ health
- Immune status
- Metabolic state
- Regenerative capacity
- Disease progression
- Therapeutic response
This atlas serves as the foundational diagnostic framework for all HEMOREGEN biomarker, liquid biopsy, companion diagnostic, and digital twin platforms.
SECTION I — EV BIOMARKER CLASSIFICATION HIERARCHY
Tier I
Universal EV Identity Biomarkers
Purpose:
Confirm EV origin and integrity.
Canonical EV Markers
Marker | Function |
CD9 | EV identity |
CD63 | Endosomal origin |
CD81 | Membrane integrity |
TSG101 | EV biogenesis |
ALIX | EV formation |
Tier II
Source Attribution Biomarkers
Purpose:
Identify tissue or cellular origin.
Tier III
Functional Biomarkers
Purpose:
Determine biological activity.
Tier IV
Disease Biomarkers
Purpose:
Identify pathology-specific signaling.
Tier V
Therapeutic Biomarkers
Purpose:
Monitor treatment response.
SECTION II — CELL-OF-ORIGIN BIOMARKER ATLAS
Immune Cell EV Markers
Cell Type | Biomarkers |
T Cells | CD3, CD4, CD8 |
Regulatory T Cells | FOXP3, CD25, CTLA-4 |
B Cells | CD19, CD20 |
NK Cells | CD56, NKG2D |
Monocytes | CD14 |
Dendritic Cells | CD11c, HLA-DR |
Vascular EV Markers
Source | Biomarkers |
Endothelium | CD31, VE-Cadherin |
Platelets | CD41, CD61 |
Smooth Muscle | ACTA2-associated markers |
Organ-Derived EV Markers
Organ | Biomarkers |
Liver | miR-122, ASGPR-associated markers |
Brain | Neural adhesion molecules, miR-124 |
Heart | Cardiac troponin-associated cargo |
Kidney | Nephron-associated proteins |
Lung | Surfactant-associated proteins |
Gut | Intestinal epithelial markers |
SECTION III — BIOMARKER CARGO TAXONOMY
RNA Biomarkers
MicroRNA Layer
Biomarker | Functional Association |
miR-21 | Inflammation, cancer |
miR-155 | Immune activation |
miR-146a | Immune regulation |
miR-122 | Liver physiology |
miR-124 | Neural biology |
miR-210 | Hypoxia response |
Long Non-Coding RNAs
Applications:
- Disease classification
- Progression monitoring
- Therapeutic tracking
Circular RNAs
Applications:
- Chronic disease monitoring
- Stability biomarkers
Protein Biomarkers
Immune Biomarkers
- IL-6
- IL-10
- TNF-α
- IFN-associated proteins
Regenerative Biomarkers
- VEGF
- HGF
- Amphiregulin
- IGF-associated proteins
Checkpoint Biomarkers
- PD-L1
- CTLA-4-associated proteins
- TIM-3-associated cargo
- LAG3-associated cargo
Metabolic Biomarkers
- NAD+-associated regulators
- Mitochondrial RNAs
- ATP-associated signaling proteins
- Redox-associated cargo
SECTION IV — IMMUNE BIOMARKER ATLAS
APC Priming Biomarkers
Derived From:
HEMOREGEN-IMM-001
Core Biomarkers
- MHC-I peptide complexes
- MHC-II peptide complexes
- CD80
- CD86
- IL-12
- miR-155
Tolerance Biomarkers
Derived From:
HEMOREGEN-IMM-002
Core Biomarkers
- FOXP3-associated cargo
- IL-10
- TGFβ
- CTLA-4
- PD-L1
- miR-146a
Cytotoxic Biomarkers
Derived From:
HEMOREGEN-IMM-003
Core Biomarkers
- Granzyme B
- FasL
- TRAIL
- IFN-γ
- NKG2D
Exhaustion Biomarkers
Derived From:
HEMOREGEN-IMM-005
Core Biomarkers
- PD-1-associated cargo
- PD-L1
- TOX-associated transcripts
- IL-27
- TIM-3-associated cargo
SECTION V — DISEASE BIOMARKER REFERENCE LIBRARY
Oncology Biomarker Profile
Signature Components
- PD-L1
- miR-21
- miR-210
- VEGF
- Tumor-specific proteins
Applications:
- Early detection
- Minimal residual disease
- Metastatic surveillance
Autoimmune Biomarker Profile
Signature Components
- Reduced tolerance markers
- Elevated inflammatory cargo
- Self-reactive communication signatures
Applications:
- Disease activity monitoring
- Flare prediction
Chronic Infection Biomarker Profile
Signature Components
- Exhaustion-associated markers
- Reservoir-support signals
- Persistent inflammatory cargo
Applications:
- Persistence monitoring
- Recovery assessment
Neurodegeneration Biomarker Profile
Signature Components
- Neuroinflammatory cargo
- Synaptic regulatory proteins
- Neural miRNAs
Applications:
- Disease progression monitoring
Fibrosis Biomarker Profile
Signature Components
- TGFβ
- ECM remodeling proteins
- Fibrogenic RNAs
Applications:
- Organ fibrosis monitoring
SECTION VI — BIOMARKER PERFORMANCE FRAMEWORK
Domain A
Sensitivity
Score:
0–20
Domain B
Specificity
Score:
0–20
Domain C
Reproducibility
Score:
0–20
Domain D
Clinical Utility
Score:
0–20
Domain E
Translational Readiness
Score:
0–20
EV Biomarker Utility Index (EBUI)
Total Score:
0–100
Score | Interpretation |
80–100 | Clinical-grade biomarker |
60–79 | High-value research biomarker |
40–59 | Emerging biomarker |
20–39 | Exploratory biomarker |
<20 | Low-value biomarker |
SECTION VII — COMPANION DIAGNOSTIC ARCHITECTURE
CDX Module A
Immune Monitoring
Applications:
- Immunotherapy
- Autoimmune disease
CDX Module B
Oncology Monitoring
Applications:
- Tumor burden
- Response prediction
CDX Module C
Regenerative Monitoring
Applications:
- Tissue repair
- Stem-cell therapies
CDX Module D
Communication Integrity Monitoring
Applications:
- Connectome assessment
- Network dysfunction detection
SECTION VIII — DIGITAL TWIN BIOMARKER INTEGRATION
Biomarker inputs feed directly into:
- HEMOREGEN-COMM-005 Simulation Engine
- Human Organ Communication Connectome
- Digital Twin Models
- Disease Forecasting Systems
Outputs:
- Risk scores
- Disease progression forecasts
- Therapeutic response predictions
SECTION IX — HEMOREGEN DIAGNOSTIC ENGINEERING BLUEPRINT
HEM-DX-RX-001
Universal EV Biomarker Platform
Applications:
- Multi-disease screening
HEM-DX-RX-002
Precision Immune Monitoring Platform
Applications:
- Immunotherapy management
HEM-DX-RX-003
Liquid Biopsy Biomarker Platform
Applications:
- Oncology diagnostics
HEM-DX-RX-004
Regenerative Monitoring Platform
Applications:
- Tissue engineering
- Organ repair
HEM-DX-RX-005
Digital Twin Biomarker Platform
Applications:
- Predictive medicine
- Personalized health modeling
TRANSLATIONAL DEVELOPMENT ROADMAP
H1 — Biomarker Discovery
- Multi-omic profiling
- Source attribution
H2 — Analytical Validation
- Assay development
- Reproducibility studies
H3 — Clinical Validation
- Cohort studies
- Longitudinal biomarker tracking
H4 — Companion Diagnostic Development
- Regulatory pathway development
- Clinical utility assessment
H5 — Clinical Deployment
- Precision diagnostics
- Population screening
- Digital twin integration
NEXT DELIVERABLE
HEMOREGEN-DX-002 — EV Liquid Biopsy Platform
Will establish:
- Blood-based EV diagnostic architecture
- Cancer liquid biopsy systems
- Multi-disease detection algorithms
- Longitudinal disease monitoring
- Minimal residual disease detection
- Precision companion diagnostic workflows
MASTER REGISTRY INDEX
HEMOREGEN-DX-001 — EV Biomarker Reference Atlas
HEM-DX-RX-001 — Universal EV Biomarker Platform
HEM-DX-RX-002 — Precision Immune Monitoring Platform
HEM-DX-RX-003 — Liquid Biopsy Biomarker Platform
HEM-DX-RX-004 — Regenerative Monitoring Platform
HEM-DX-RX-005 — Digital Twin Biomarker Platform
HEMOREGEN-721-PROG-0001 — Project HEMOREGEN-721 Master Program
SCF-EV-BIO-0001 — EV Biomarker Systems Atlas
SCF-EV-CDX-0001 — Companion Diagnostic Framework
SCF-EV-DIAG-0001 — Precision EV Diagnostic Architecture